--- title: "Berberine HCl 500 mg (AMPK) — Evidence, Benefits & Where to… | Magellan" description: "Berberine HCl 500 mg (AMPK) — Berberine is a naturally occurring isoquinoline (benzylisoquinoline) alkaloid found in plants such as Coptis chinensis…" url: "https://magellanlongevity.com/p/9.md" canonical: "https://magellanlongevity.com/p/9.html" html: "https://magellanlongevity.com/p/9.html" type: "product" section: "Nutraceuticals & Cellular Energizers" evidence_grade: "Moderate evidence" evidence_tier: "moderate" citations: 18 product_id: 9 price_usd: 18.95 updated: 2026-09-02 author: "Gabriel Radu, DO" author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765." publisher: "Magellan Longevity" content_format: "markdown" license: "Educational content — not medical advice" --- # Berberine HCl 500 mg (AMPK) [Home](https://magellanlongevity.com/) › [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) › Berberine HCl 500 mg (AMPK) **HTML version:** https://magellanlongevity.com/p/9.html · **In the Magellan app:** https://magellanlongevity.com/#/product/9 ## Key facts | Field | Value | | --- | --- | | Product | Berberine HCl 500 mg (AMPK) | | Category | [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) | | Evidence grade | Moderate evidence (B) | | Peer-reviewed citations | 18 | | Typical listed price | $18.95 (check the live price) | | Where to buy | [Search Amazon](https://www.amazon.com/s?k=Berberine%20HCl%20500%20mg%20%28AMPK%29&tag=magellanlong-20) | | Catalog ID | 9 | ## What it is Berberine is a naturally occurring isoquinoline (benzylisoquinoline) alkaloid found in plants such as Coptis chinensis (Chinese goldthread), Berberis vulgaris (barberry), Hydrastis canadensis (goldenseal), Berberis aquifolium (Oregon grape) and Berberis aristata, with a long history of use in traditional Chinese and Ayurvedic medicine. Pharmacologically it activates AMP-activated protein kinase (AMPK), a central regulator of cellular energy balance, and modulates glucose and lipid metabolism, inhibits hepatic gluconeogenesis, and alters the gut microbiota. These mechanisms underlie its investigation as an oral agent for type 2 diabetes, dyslipidemia and other metabolic conditions. ## Its role in longevity In randomized trials and their meta-analyses in type 2 diabetes, berberine has produced significant reductions in fasting glucose (about 0.8 mmol/L), HbA1c (about 0.6–0.9%), total and LDL cholesterol and triglycerides, and one pilot trial found 0.5 g three times daily lowered HbA1c from 9.5% to 7.5% over three months — comparable to metformin in the parallel arm. Weight-loss effects are small and inconsistent despite social-media 'nature's Ozempic' claims. However, the trial base is dominated by small, short, mostly Chinese studies of variable quality, large rigorous confirmatory trials are lacking, and effects on hard clinical outcomes are unproven; berberine is not a substitute for prescribed medications such as metformin or statins. Gastrointestinal upset is common, oral bioavailability is low, and berberine inhibits CYP3A4 and CYP2D6, so it interacts with many medications. This evidence describes the berberine compound and its AMPK-linked metabolic mechanisms rather than this specific commercial product. ## Evidence grade: Moderate evidence - **What the grade means:** Curated grade based on the human and mechanistic evidence for this compound. - **Dose used in studies:** Human trials typically use berberine HCl 500 mg two to three times daily (about 1,000–1,500 mg/day) for 8–24 weeks, lowering blood glucose and lipids comparably to metformin in some studies. - **Dose from food:** Not meaningfully obtained from food: berberine comes from medicinal plants (barberry, goldenseal, Oregon grape root) used as extracts; edible barberry berries contain only traces, so matching a 500 mg dose from food is impractical. - **What this grade does not say:** Meta-analyses of dozens of RCTs show metformin-like reductions in fasting glucose and HbA1c (~0.6–0.9%), but the trial base is small, short and mostly Chinese, with no large rigorous confirmatory trials and no hard-outcome data. Weight-loss effects are weak despite 'nature's Ozempic' hype. GI upset is common and berberine inhibits CYP3A4/2D6, so drug interactions are a real concern — not a substitute for prescribed medication. ## Where it comes from without a bottle Food, exercise and behaviour routes to the same pathway, each with its citation. | Natural source | How it works | Citation | | --- | --- | --- | | Barberries (closest culinary source) | Berberine isn't common in everyday food — the closest culinary source is the dried barberry (zereshk), used in Persian rice dishes. Its fruit, bark, and root all carry the alkaloid, but in far smaller amounts than a supplement. | Phytotherapy Research 2008 [PMID 18618524](https://pubmed.ncbi.nlm.nih.gov/18618524/) | | Exercise & fasting (the AMPK pathway) | Since berberine isn't really a dietary nutrient, the honest lifestyle equivalent is its mechanism: berberine activates AMPK, the cellular energy sensor. Aerobic exercise and fasting switch on the same AMPK pathway — a free way to hit the same target. | PNAS 2007 [PMID 17609368](https://pubmed.ncbi.nlm.nih.gov/17609368/) | ### What those papers actually say 1. **Barberries (closest culinary source)** Phytotherapy Research 2008 · [PMID 18618524](https://pubmed.ncbi.nlm.nih.gov/18618524/) · [DOI 10.1002/ptr.2399](https://doi.org/10.1002/ptr.2399) > various parts of this plant including its root, bark, leaf and fruit have been used as folk medicine 2. **Exercise & fasting (the AMPK pathway)** PNAS 2007 · [PMID 17609368](https://pubmed.ncbi.nlm.nih.gov/17609368/) · [DOI 10.1073/pnas.0705070104](https://doi.org/10.1073/pnas.0705070104) > PGC-1alpha gene expression is induced by exercise and by chemical activation of AMPK in skeletal muscle ## In the news - **Berberine: What It Is, Benefits and Side Effects** — Cleveland Clinic 2025 [Read it](https://health.clevelandclinic.org/berberine) > Research shows it may be effective for several chronic diseases, including diabetes, cardiovascular disorders and inflammatory diseases. But most studies are small, not well-designed and need to be interpreted with caution. - **Is Berberine Really “Nature's Ozempic”? What Science Says** — News-Medical 2025 [Read it](https://www.news-medical.net/health/Is-Berberine-Really-e2809cNaturee28099s-Ozempice2809d-What-Science-Says.aspx) > Pharmacologically, Berberine activates AMP-activated protein kinase (AMPK), which is crucial for regulating cellular energy balance. It also modulates lipid and glucose metabolism, showing promise in managing metabolic diseases like diabetes and hyperlipidemia. ## The research Peer-reviewed studies on the active compound. Quotes are verbatim from the cited abstract. Research describes the active mechanism and is not a claim about this specific product. ### Cited studies 1. **The effect of Berberine on weight loss in order to prevent obesity: A systematic review** Biomedicine & Pharmacotherapy 2020 · [PMID 32353823](https://pubmed.ncbi.nlm.nih.gov/32353823/) · [DOI 10.1016/j.biopha.2020.110137](https://doi.org/10.1016/j.biopha.2020.110137) > Berberine and its effect on management of obesity and the related metabolic consequences were evaluated across in vitro, animal and human studies. 2. **The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis** Clin Ther 2023 · [PMID 38016844](https://pubmed.ncbi.nlm.nih.gov/38016844/) · [DOI 10.1016/j.clinthera.2023.10.019](https://doi.org/10.1016/j.clinthera.2023.10.019) > berberine was effective in reducing fasting blood glucose and hemoglobin A1C 3. **The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.** Oxid Med Cell Longev 2021 · [PMID 34956436](https://pubmed.ncbi.nlm.nih.gov/34956436/) · [DOI 10.1155/2021/2074610](https://doi.org/10.1155/2021/2074610) > Analysis of berberine applied alone or with standard diabetic therapies versus the control group revealed significant reductions in HbA1c (MD = -0.73; 95% CI (-0.97, -0.51)), FPG (MD = -0.86, 95% CI (-1.10, -0.62)), and 2hPG (MD = -1.26, 95% CI (-1.64, -0.89)). 4. **Probiotics, synbiotics and berberine in Type 2 diabetes mellitus: A systematic review, meta-analysis, and molecular dynamics simulation study.** PLoS One 2026 · [PMID 42213651](https://pubmed.ncbi.nlm.nih.gov/42213651/) · [DOI 10.1371/journal.pone.0348907](https://doi.org/10.1371/journal.pone.0348907) > Probiotics, synbiotics, and BBR provide statistically significant but clinically modest improvements in glycemic control. These findings support their use as adjunctive, rather than primary, therapeutic options and highlight the need for larger and longer trials with standardized interventions. 5. **Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis.** Evid Based Complement Alternat Med 2012 · [PMID 23118793](https://pubmed.ncbi.nlm.nih.gov/23118793/) · [DOI 10.1155/2012/591654](https://doi.org/10.1155/2012/591654) > Berberine appeared to be efficacious for treating hyperglycaemia and dyslipidemia in T2DM. However, the evidence of berberine for treating T2DM should be carefully interpreted due to the low methodological quality, small sample size, limited number of trials, and unidentified risks of bias. 6. **Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.** J Ethnopharmacol 2014 · [PMID 25498346](https://pubmed.ncbi.nlm.nih.gov/25498346/) · [DOI 10.1016/j.jep.2014.09.049](https://doi.org/10.1016/j.jep.2014.09.049) > This study indicates that berberine has comparable therapeutic effect on type 2 DM, hyperlipidemia and hypertension with no serious side effect. 7. **Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.** Drugs 2023 · [PMID 36941490](https://pubmed.ncbi.nlm.nih.gov/36941490/) · [DOI 10.1007/s40265-023-01841-4](https://doi.org/10.1007/s40265-023-01841-4) > Berberine produces small reductions in LDL cholesterol, triglycerides, and apolipoprotein B, with potential sex-specific effects on HDL cholesterol. Large-scale trials that consider sex disparity and assess clinical outcomes are required. 8. **Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials.** Phytomedicine 2018 · [PMID 30466986](https://pubmed.ncbi.nlm.nih.gov/30466986/) · [DOI 10.1016/j.phymed.2018.09.212](https://doi.org/10.1016/j.phymed.2018.09.212) > Berberine improves lipid profiles in dyslipidaemias with satisfactory safety. Nevertheless, these findings should be interpreted with caution because of the high clinical heterogeneity and high risk of bias in the included trials. 9. **The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials.** Planta Med 2013 · [PMID 23512497](https://pubmed.ncbi.nlm.nih.gov/23512497/) · [DOI 10.1055/s-0032-1328321](https://doi.org/10.1055/s-0032-1328321) > In conclusion, berberine may have beneficial effects in the control of blood lipid levels. However, the efficacy of berberine in treating hyperlipidemia should be further evaluated by more randomized controlled trials in a larger population of patients. 10. **Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.** Am J Chin Med 2019 · [PMID 31094214](https://pubmed.ncbi.nlm.nih.gov/31094214/) · [DOI 10.1142/S0192415X19500393](https://doi.org/10.1142/S0192415X19500393) > This study suggests that berberine is effective for hyperlipidemia. The quality and quantity of included studies, however, were dissatisfactory, which might decrease the reliability of the results. 11. **Efficacy and safety of berberine for several cardiovascular diseases: A systematic review and meta-analysis of randomized controlled trials.** Phytomedicine 2023 · [PMID 36805484](https://pubmed.ncbi.nlm.nih.gov/36805484/) · [DOI 10.1016/j.phymed.2023.154716](https://doi.org/10.1016/j.phymed.2023.154716) > This study suggests that berberine may be a promising alternative for CVDs with no serious adverse reactions. However, our results may be limited by the quality of existing research. 12. **Metabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trials.** Phytother Res 2019 · [PMID 30632209](https://pubmed.ncbi.nlm.nih.gov/30632209/) · [DOI 10.1002/ptr.6282](https://doi.org/10.1002/ptr.6282) > The present findings suggest that the coadministration of berberine and silymarin is associated with an advantageous improvement in lipid and glucose profile, suggesting the possible use of this nutraceutical combination in order to promote the cardiometabolic health. 13. **Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials.** Clin Investig Arterioscler 2016 · [PMID 27131395](https://pubmed.ncbi.nlm.nih.gov/27131395/) · [DOI 10.1016/j.arteri.2016.03.002](https://doi.org/10.1016/j.arteri.2016.03.002) > This meta-analysis confirms that the nutraceutical combination containing berberine, policosanol, and red yeast rice has shown to be an effective product for the improvement of the lipid profile. 14. **The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials.** Clin Nutr ESPEN 2020 · [PMID 32690176](https://pubmed.ncbi.nlm.nih.gov/32690176/) · [DOI 10.1016/j.clnesp.2020.04.010](https://doi.org/10.1016/j.clnesp.2020.04.010) > Berberine treatment moderately but significantly decreased body weight (WMD = -2.07 kg, 95% CI -3.09, -1.05, P < 0.001), body mass index (BMI) (WMD = -0.47 kg/m, 95% CI -0.70, -0.23, P < 0.001), waist circumference (WC) (WMD = -1.08 cm, 95% CI -1.97, -0.19, P = 0.018) 15. **The effects of berberine on inflammatory markers in Chinese patients with metabolic syndrome and related disorders: a meta-analysis of randomized controlled trials.** Inflammopharmacology 2022 · [PMID 35352233](https://pubmed.ncbi.nlm.nih.gov/35352233/) · [DOI 10.1007/s10787-022-00976-2](https://doi.org/10.1007/s10787-022-00976-2) > Overall, the use of berberine in patients with MetS and related disorders appeared to significantly decrease several inflammatory markers. Further multi-center and rigorous investigations with larger patient populations are encouraged to confirm the effect of berberine on MetS and related disorders. 16. **Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence.** Biomed Pharmacother 2020 · [PMID 33186794](https://pubmed.ncbi.nlm.nih.gov/33186794/) · [DOI 10.1016/j.biopha.2020.110984](https://doi.org/10.1016/j.biopha.2020.110984) > The therapeutic effects of BBR are based on regulating various metabolic aspects and pathophysiological procedures. For example, it can promote insulin secretion, improve insulin resistance, inhibit lipogenesis, alleviate adipose tissue fibrosis, reduce hepatic steatosis, and improve gut microbiota disorders. 17. **Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis.** Frontiers in pharmacology 2022 · [PMID 36467075](https://pubmed.ncbi.nlm.nih.gov/36467075/) > Across 37 RCTs (n=3,048) in type 2 diabetes, berberine lowered fasting glucose by about 0.82 mmol/L and HbA1c by about 0.63% without increasing hypoglycemia — though the underlying trials were mostly small and of variable quality. 18. **Efficacy of berberine in patients with type 2 diabetes mellitus.** Metabolism: clinical and experimental 2008 · [PMID 18442638](https://pubmed.ncbi.nlm.nih.gov/18442638/) > In a pilot RCT, berberine 0.5 g three times daily lowered HbA1c from 9.5% to 7.5% over 3 months — comparable to metformin in the parallel arm — with transient gastrointestinal effects in about a third of patients. ## Where to buy [Search Amazon for Berberine HCl 500 mg (AMPK)](https://www.amazon.com/s?k=Berberine%20HCl%20500%20mg%20%28AMPK%29&tag=magellanlong-20) — affiliate search link. ## Structured data ```json {"@context":"https://schema.org","@graph":[{"@type":"ItemPage","@id":"https://magellanlongevity.com/p/9.html#page","url":"https://magellanlongevity.com/p/9.html","name":"Berberine HCl 500 mg (AMPK)","description":"Berberine is a naturally occurring isoquinoline (benzylisoquinoline) alkaloid found in plants such as Coptis chinensis (Chinese goldthread), Berberis…","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/p/9.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Nutraceuticals & Cellular Energizers","item":"https://magellanlongevity.com/c/1.html"},{"@type":"ListItem","position":3,"name":"Berberine HCl 500 mg (AMPK)","item":"https://magellanlongevity.com/p/9.html"}]},{"@type":"Product","@id":"https://magellanlongevity.com/p/9.html#product","name":"Berberine HCl 500 mg (AMPK)","category":"Nutraceuticals & Cellular Energizers","url":"https://magellanlongevity.com/p/9.html","description":"Berberine is a naturally occurring isoquinoline (benzylisoquinoline) alkaloid found in plants such as Coptis chinensis (Chinese goldthread), Berberis vulgaris (barberry), Hydrastis canadensis (goldenseal), Berberis aquifolium (Oregon grape) and Berberis aristata, with a long history of use in…","additionalProperty":[{"@type":"PropertyValue","name":"Evidence grade","value":"Moderate evidence"}],"offers":{"@type":"Offer","priceCurrency":"USD","price":"18.95","url":"https://www.amazon.com/s?k=Berberine%20HCl%20500%20mg%20%28AMPK%29&tag=magellanlong-20","availability":"https://schema.org/InStock"}}]} ``` ## Related on Magellan Longevity - [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md) — Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum triglycerides… - [Creatine Monohydrate](https://magellanlongevity.com/p/123.md) — Across meta-analyses and randomized trials, creatine monohydrate combined with resistance training modestly… - [Astaxanthin Softgels](https://magellanlongevity.com/p/107.md) — In humans, randomized trials and meta-analyses most consistently show that astaxanthin lowers the… - [Zinc Picolinate](https://magellanlongevity.com/p/133.md) — Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after symptom onset, can… - [Vitamin K2 (MK-7)](https://magellanlongevity.com/p/138.md) — In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating… - [All Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) - [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md) - [Longevity research map](https://magellanlongevity.com/longevity-research-map.html) ## Scope and disclosures Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication. Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases. Reviewed for accuracy by a board-certified physician (DO).